Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Sani-Care Salon Products, Inc.
WARNING LETTER
•Sani-Care Salon Products, Inc.•November 3, 2023

Sani-Care Salon Products, Inc. – FDA Warning Letter, Nov 3, 2023

Record Details

The FDA issued a Warning Letter to Sani-Care Salon Products, Inc. following an inspection from October 31 to November 3, 2023, identifying significant Current Good Manufacturing Practice (CGMP) violations for finished pharmaceuticals. The drug products are deemed adulterated.

Key violations include: 1. **Inadequate Quality Control Unit (QCU):** The firm's QCU failed to ensure drug products comply with CGMP and meet specifications. This includes lacking an adequate QCU, not validating the water system, and not having a procedure to monitor water quality. Corrective actions require robust procedures, QCU oversight, complete batch reviews, and approval of investigations. 2. **Insufficient Finished Product Testing:** The firm failed to conduct appropriate laboratory testing for finished drug products, including identity, strength, impurity, and microbiological attributes. No finished drug product specifications were established since manufacturing began in November 2020. An action plan for testing retain samples of all distributed batches within expiry is required. 3. **Failure to Test Components:** The firm did not verify the identity of each component or validate supplier test analyses. Active pharmaceutical ingredient (API) was released based on a Certificate of Analysis (COA) without identity testing or validation. Additionally, expired API was used in production.

The FDA strongly recommends engaging a qualified CGMP consultant. The firm is responsible for the quality of drugs produced as a contract facility. Failure to address these violations

Company
Sani-Care Salon Products, Inc.
Inspection date
November 3, 2023
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations II
Person
  • Monica R. Maxwell (Program Division Director)
View Company Profile

ID · f99b5c7c-33cb-4739-a839-5a1776b7423e

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.2221 CFR 211.100(a)21 CFR 211.165(a)21 CFR 211.165(b)21 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 CFR 211.3421 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sani-Care Salon Products, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.